HealthpointCapital

What is HealthpointCapital?

HealthpointCapital is a private equity firm exclusively focused on the orthopedic and dental device sectors. They manage $750 million in institutional capital, targeting growth businesses within the musculoskeletal industry, where they can obtain a controlling or significant equity stake.

HealthpointCapital is renowned in the musculoskeletal healthcare field as they speak the language, understand the procedures, and have astute clinical data analysis capabilities to identify open white space opportunities. Their investment approach is values-driven and research-based, with relationships and trust at the core of their operations.

Extensive research underpins every decision they make. With their deep private equity and investing experience, HealthpointCapital has a solid track record of building funds, mentoring portfolio operations, and transacting successfully. They bring real leadership experience in musculoskeletal healthcare, having accelerated performance in both top firms and high-growth opportunities and turnarounds.

As part of their portfolio strategy, they have invested in more companies within the orthopedic sector than any other dedicated healthcare investment firm and have significant relationships with strategic acquirers at the CEO level. Their investment goal is to find innovative, emerging, and established companies that would benefit from focus, mentorship, and investment, aligning their interests with their partners to accelerate growth and create substantial value.

They have made a series of 12 investments since 2004, creating five platform companies, invested over $325 million in equity capital, and have seen their portfolio companies increase revenues more than 2.5 times from the initial time of investment, with an average holding period of just 1.5 years.

They have achieved the successful initial public offering of Alphatec Spine and the full sale of Nexa Orthopedics.

HealthpointCapital invests with a fund investment minimum of $5,000,000 and a maximum of $15,000,000.

What they say:

We are a values-based, research-driven private equity firm.

What we look for: We invest exclusively in the musculoskeletal industry, including medtech and robotics.